Gingival Crevicular Fluid IL-6, TPA, PAI-2, Albumin Levels Following Initial Periodontal Treatment in Chronic Periodontitis Patients with or Without Type 2 Diabetes

Overview

Journal Inflamm Res

Specialties Allergy & Immunology
Pathology

Date 2010 Sep 17

PMID 20845058

Citations 22

Authors

Levent Kardesler

Nurcan Buduneli

Sevki Cetinkalp

David Lappin

Denis F Kinane

Affiliations

Soon will be listed here.

Abstract

Objectives: To evaluate initial periodontal treatment effects on gingival crevicular fluid (GCF) interleukin-6 (IL-6), tissue-type plasminogen activator (tPA), plasminogen activator inhibitor-2 (PAI-2), albumin levels in type 2 diabetic patients.

Design And Methods: GCF samples were collected from 20 type 2 diabetic, 22 non-diabetic non-smokers all with chronic periodontitis at baseline, 1-, 3-months following initial periodontal treatment. Biochemical analysis was performed by ELISA. Data were tested by Mann-Whitney U, Wilcoxon tests.

Results: The total amounts of albumin, IL-6, tPA, PAI-2 decreased significantly in diabetics after treatment (1- and 3-months) whereas, only PAI-2 decreased in non-diabetic group at 3-months (p < 0.05). There were statistically significant differences between the diabetics and non-diabetics at all time points for albumin, PAI-2 and at 1-, 3-months for GCF volume (p < 0.050) but only at baseline for IL-6 (p < 0.050).

Conclusion: Present data suggest clinical improvements are less apparent in diabetic chronic periodontitis patients as reflected by disease markers in GCF and by an increase in concentrations of inflammatory proteins IL-6, tPA, and PAI-2 in GCF of this patient group following initial periodontal treatment.

Citing Articles

Impact of Photoactivated Curcumin on Proliferation of Experimentally Induced Periodontitis and Diabetic Gingival Fibroblast Cell Line.

Sharma A, Bains V, Chandra C, Srivastava R, Soi S, Singh U J Pharm Bioallied Sci. 2025; 16(Suppl 5):S4844-S4849.

PMID: 40061755 PMC: 11888664. DOI: 10.4103/jpbs.jpbs_1283_24.

Salivary features of periodontitis and gingivitis in type 2 diabetes mellitus.

Ebersole J, Kirakodu S, Zhang X, Dawson 3rd D, Miller C Sci Rep. 2024; 14(1):30649.

PMID: 39730430 PMC: 11680937. DOI: 10.1038/s41598-024-77434-2.

Effect of Low-Level Laser Therapy on Early Wound Healing and Levels of Inflammatory Mediators in Gingival Crevicular Fluid Following Open Flap Debridement.

Misra P, Kalsi R, Anand Arora S, Singh K, Athar S, Saini A Cureus. 2023; 15(2):e34755.

PMID: 36909061 PMC: 9999105. DOI: 10.7759/cureus.34755.

Impact of Air and Manual Scaling on Dental Anxiety and Blood Glucose Level among Diabetic Patients.

Alwan A, A Mousa H, Talib H, Jassim T J Int Soc Prev Community Dent. 2021; 11(5):510-515.

PMID: 34760794 PMC: 8533038. DOI: 10.4103/jispcd.JISPCD_411_20.

Association of periodontal pocket area with type 2 diabetes and obesity: a cross-sectional study.

Takeda K, Mizutani K, Minami I, Kido D, Mikami R, Konuma K BMJ Open Diabetes Res Care. 2021; 9(1).

PMID: 33879517 PMC: 8061845. DOI: 10.1136/bmjdrc-2021-002139.

References

Page R, Eke P . Case definitions for use in population-based surveillance of periodontitis. J Periodontol. 2007; 78(7 Suppl):1387-99. DOI: 10.1902/jop.2007.060264. View

Kurtis B, Develioglu H, Taner I, Balos K, Tekin I . IL-6 levels in gingival crevicular fluid (GCF) from patients with non-insulin dependent diabetes mellitus (NIDDM), adult periodontitis and healthy subjects. J Oral Sci. 2000; 41(4):163-7. DOI: 10.2334/josnusd.41.163. View

Goncalves D, Correa F, Khalil N, de Faria Oliveira O, Orrico S . The effect of non-surgical periodontal therapy on peroxidase activity in diabetic patients: a case-control pilot study. J Clin Periodontol. 2008; 35(9):799-806. DOI: 10.1111/j.1600-051X.2008.01289.x. View

Shlossman M, Knowler W, Pettitt D, Genco R . Type 2 diabetes mellitus and periodontal disease. J Am Dent Assoc. 1990; 121(4):532-6. DOI: 10.14219/jada.archive.1990.0211. View

ASTEDT B, Hagerstrand I, Lecander I . Cellular localisation in placenta of placental type plasminogen activator inhibitor. Thromb Haemost. 1986; 56(1):63-5. View

OConnell P, Taba M, Nomizo A, Foss Freitas M, Suaid F, Uyemura S . Effects of periodontal therapy on glycemic control and inflammatory markers. J Periodontol. 2008; 79(5):774-83. DOI: 10.1902/jop.2008.070250. View

Eliasson M, Jansson J, Lindahl B, Stegmayr B . High levels of tissue plasminogen activator (tPA) antigen precede the development of type 2 diabetes in a longitudinal population study. The Northern Sweden MONICA study. Cardiovasc Diabetol. 2003; 2:19. PMC: 328088. DOI: 10.1186/1475-2840-2-19. View

Lamster I, Oshrain R, Gordon J . Enzyme activity in human gingival crevicular fluid: considerations in data reporting based on analysis of individual crevicular sites. J Clin Periodontol. 1986; 13(8):799-804. DOI: 10.1111/j.1600-051x.1986.tb00885.x. View

Christgau M, Palitzsch K, Schmalz G, Kreiner U, Frenzel S . Healing response to non-surgical periodontal therapy in patients with diabetes mellitus: clinical, microbiological, and immunologic results. J Clin Periodontol. 1998; 25(2):112-24. DOI: 10.1111/j.1600-051x.1998.tb02417.x. View

10.

Kinnby B, Matsson L, ASTEDT B . Aggravation of gingival inflammatory symptoms during pregnancy associated with the concentration of plasminogen activator inhibitor type 2 (PAI-2) in gingival fluid. J Periodontal Res. 1996; 31(4):271-7. DOI: 10.1111/j.1600-0765.1996.tb00493.x. View

11.

da Cruz G, Toledo S, Sallum E, Sallum A, Ambrosano G, Sardi J . Clinical and laboratory evaluations of non-surgical periodontal treatment in subjects with diabetes mellitus. J Periodontol. 2008; 79(7):1150-7. DOI: 10.1902/jop.2008.070503. View

12.

Ryan M, Carnu O, Kamer A . The influence of diabetes on the periodontal tissues. J Am Dent Assoc. 2008; 134 Spec No:34S-40S. DOI: 10.14219/jada.archive.2003.0370. View

13.

Kiran M, Arpak N, Unsal E, Erdogan M . The effect of improved periodontal health on metabolic control in type 2 diabetes mellitus. J Clin Periodontol. 2005; 32(3):266-72. DOI: 10.1111/j.1600-051X.2005.00658.x. View

14.

Yin X, Bunn C, Bartold P . Detection of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 2(PAI-2) in gingival crevicular fluid from healthy, gingivitis and periodontitis patients. J Clin Periodontol. 2000; 27(3):149-56. DOI: 10.1034/j.1600-051x.2000.027003149.x. View

15.

Kardesler L, Buduneli N, Cetinkalp S, Kinane D . Adipokines and inflammatory mediators after initial periodontal treatment in patients with type 2 diabetes and chronic periodontitis. J Periodontol. 2010; 81(1):24-33. DOI: 10.1902/jop.2009.090267. View

16.

Lalla E, Lamster I, Feit M, Huang L, Spessot A, Qu W . Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J Clin Invest. 2000; 105(8):1117-24. PMC: 300834. DOI: 10.1172/JCI8942. View

17.

. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2006; 30 Suppl 1:S42-7. DOI: 10.2337/dc07-S042. View

18.

Tsai C, Hayes C, Taylor G . Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol. 2002; 30(3):182-92. DOI: 10.1034/j.1600-0528.2002.300304.x. View

19.

Emrich L, Shlossman M, Genco R . Periodontal disease in non-insulin-dependent diabetes mellitus. J Periodontol. 1991; 62(2):123-31. DOI: 10.1902/jop.1991.62.2.123. View

20.

Rodrigues D, Taba M, Novaes A, Souza S, Grisi M . Effect of non-surgical periodontal therapy on glycemic control in patients with type 2 diabetes mellitus. J Periodontol. 2003; 74(9):1361-7. DOI: 10.1902/jop.2003.74.9.1361. View